CD38 and Miyoshi myopathy: Therefore, in the further evaluation of TRE-CD38-CAR T cells we not only tested their anti-MM activity but also evaluated the potential off-tumor toxicities against CD38int normal hematopoietic cells upon exposure and after removal of DOX.